Mahmoud S. Assaf, Ms, MBA
About Mahmoud S. Assaf, Ms, MBA
Mahmoud S. Assaf, Ms, MBA, is the Director of Strategic Program Management at both Bristol-Myers Squibb and Celgene Corporation, with over 18 years of experience in the pharmaceutical industry.
Title
Mahmoud S. Assaf holds the position of Director of Strategic Program Management at both Bristol-Myers Squibb and Celgene Corporation. His role includes overseeing strategic program management and ensuring the continuous supply of investigational products with high quality and timely execution.
Education and Expertise
Mahmoud S. Assaf has an extensive educational background related to health and technology. He is a Ph.D. candidate in Biomedical & Health Informatics at Rutgers, The State University of New Jersey-Newark. He earned his MBA in Marketing & Management of Technology from the New Jersey Institute of Technology. Mahmoud also holds an M.S. in Pharmacology & Toxicology and a B.S. in Toxicology from the University of Medicine and Dentistry of New Jersey, along with a B.S. in Clinical Laboratory Sciences from Rutgers, The State University of New Jersey-Newark.
Professional Background
Mahmoud S. Assaf has over 18 years of experience in the pharmaceutical industry. His expertise lies in drug development strategies and pharmaceutical project management. Working currently at both Bristol-Myers Squibb and Celgene Corporation, he is responsible for reinforcing processes, technology, and best practices to increase efficiency. His experience includes the design, setup, execution, reporting, and management of clinical trials.
Leadership and Team Management
Mahmoud S. Assaf has a proven ability to build and manage cross-functional clinical and project teams. His leadership skills contribute to successful drug development projects and ensure high-quality and timely execution of investigational product supplies. He is known for his capacity to boost efficiency and maintain best practices within his teams.
Achievements in Pharmaceutical Project Management
Mahmoud S. Assaf has a track record of enhancing efficiency in pharmaceutical project management. He achieves this by reinforcing processes, implementing effective technology solutions, utilizing metrics, and standardizing best practices. His work ensures the continuous and timely supply of investigational products, indicating his expertise and impact in the field.